Norma Bloy
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 27
- Cancer Immunotherapy and Biomarkers 13
- CAR-T cell therapy research 6
- Cancer Cells and Metastasis 5
- Immunology 22
- Immunotherapy and Immune Responses 15
- Immune Cell Function and Interaction 7
- Co-authors
- Lorenzo Galluzzi (28 shared papers)Aitziber Buqué (26 shared papers)Guido Kroemer (23 shared papers)laurence ZITVOGEL (15 shared papers)Alexander M.M. Eggermont (13 shared papers)Jérôme Galon (13 shared papers)Isabelle Cremer (12 shared papers)Jitka Palich Fucikova (10 shared papers)
- Journals
- OncoImmunology (19 papers)Oncotarget (2 papers)Journal of Translational Medicine (2 papers)Nature Immunology (1 paper)Nature Cancer (1 paper)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Norma Bloy
44 papers receiving 3.4k citations
Norma Bloy's Hit Papers
Peers
Comparison fields: 5 of 103
- Immunology 1.6k
- Oncology 1.5k
- Physiology 113
- Biotechnology 163
- Cancer Research 250
Countries citing papers authored by Norma Bloy
This map shows the geographic impact of Norma Bloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norma Bloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norma Bloy more than expected).
Fields of papers citing papers by Norma Bloy
This network shows the impact of papers produced by Norma Bloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norma Bloy. The network helps show where Norma Bloy may publish in the future.
Co-authors
The 25 scholars most cited alongside Norma Bloy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Consensus guidelines for the detection of immunogenic cell death Hit paper breakdown → | 2014 | 719 |
| 2 | Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance Hit paper breakdown → | 2016 | 440 |
| 3 | 2014 | 378 | |
| 4 | 2020 | 282 | |
| 5 | 2019 | 116 | |
| 6 | 2015 | 110 | |
| 7 | 2015 | 109 | |
| 8 | 2015 | 106 | |
| 9 | 2015 | 103 | |
| 10 | 2015 | 98 | |
| 11 | 2020 | 97 | |
| 12 | 2017 | 91 | |
| 13 | 2014 | 82 | |
| 14 | 2016 | 69 | |
| 15 | 2014 | 65 | |
| 16 | 2016 | 52 | |
| 17 | 2021 | 48 | |
| 18 | 2016 | 47 | |
| 19 | 2015 | 46 | |
| 20 | 2014 | 45 |
About Norma Bloy
Norma Bloy is a scholar working on Oncology, Immunology, Biotechnology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 3.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (6 papers), Autophagy in Disease and Therapy (6 papers), Cancer Research and Treatments (5 papers), Cancer Cells and Metastasis (5 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Immunology (1.6k citations), Oncology (1.5k citations), Physiology (113 citations), Biotechnology (163 citations) and Cancer Research (250 citations). Norma Bloy has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Lorenzo Galluzzi, Aitziber Buqué, Guido Kroemer, laurence ZITVOGEL, Alexander M.M. Eggermont, Jérôme Galon, Isabelle Cremer, Jitka Palich Fucikova, Radek Špíšek and Giulia Petroni. Their work appears in journals such as OncoImmunology, Oncotarget, Journal of Translational Medicine, Nature Immunology and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.